title: [Clinical study to evaluate EPA-enriched immunonutrition with ProSureTM during chemotherapy in cancer patients].
abstract: We report a prospective, single-arm, pilot study conducted by the Tokyo Metropolitan Oncology Group in order to evaluate the effect of a fish-oil enriched nutritional supplement(ProSureTM) during cancer chemotherapy in patients with advanced cancer. ProSureTM was given for more than 1 month to patients with advanced cancer whose prognosis was more than 3 months before enrollment. Laboratory data including serum albumin level, body weight, body composition, and functional status data were collected at baseline, 14 days, and 28 days. Oral supplementation consisted of 2 packs of ProSureTM per day for more than 28 days during chemotherapy. The study population included 50 patients. This study is now ongoing.
authors.affiliation: Dept. of Surgery, Tokyo Metropolitan Cancer and lnfectious Diseases Center, Japan.
authors.forename: Yoshiaki
authors.initials: Y
authors.lastname: Iwasaki
authors.forename: Manabu
authors.initials: M
authors.lastname: Ohashi
authors.forename: Tomohiro
authors.initials: T
authors.lastname: Iwanaga
authors.forename: Ryoki
authors.initials: R
authors.lastname: Ohinata
authors.forename: Keiichi
authors.initials: K
authors.lastname: Takahashi
authors.forename: Tatsuro
authors.initials: T
authors.lastname: Yamaguchi
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Matsumoto
authors.forename: Daisuke
authors.initials: D
authors.lastname: Nakano
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D015118:Eicosapentaenoic Acid / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007249:Inflammation / Q000178:diet therapy* / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000188:drug therapy*
chemical_list: D000970:Antineoplastic Agents; D015118:Eicosapentaenoic Acid